Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_4
2
67%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Completed1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (66.7%)
N/A1 (33.3%)

Trials by Status

completed133%
recruiting133%
enrolling_by_invitation133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_4

Restoring Facial Volume After GLP-1 Weight Loss With Radiesse

NCT07419854
enrolling_by_invitationnot_applicable

Using Calcium Hydroxylapatite To Treat Gum Recession and Tooth Hypersensitivity

NCT06826391
completedphase_4

Injectable Filler for Cheek Flattening

NCT01225354

Clinical Trials (3)

Showing 3 of 3 trials
NCT07419854Phase 4

Restoring Facial Volume After GLP-1 Weight Loss With Radiesse

Recruiting
NCT06826391Not Applicable

Using Calcium Hydroxylapatite To Treat Gum Recession and Tooth Hypersensitivity

Enrolling By Invitation
NCT01225354Phase 4

Injectable Filler for Cheek Flattening

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3